New directions in natural killer cell-based immunotherapy of human cancer

Author： Farag Sherif S   Fehniger Todd A   Becknell Brian   Blaser Bradley W   Caligiuri Michael A  

Publisher： Informa Healthcare

ISSN： 1471-2598

Source： Expert Opinion on Biological Therapy, Vol.3, Iss.2, 2003-04, pp. : 237-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Natural killer–dendritic cell cross-talk in cancer immunotherapy

By Kalinski Pawel   Mailliard Robbie B   Giermasz Adam   Zeh Herbert J   Basse Per   Bartlett David L   Kirkwood John M   Lotze Michael T   Herberman Ronald B  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 10, 2005-10 ,pp. : 1303-1315

Informa Healthcare

Access to resources Recommend Favorite

Natural killer: can they be useful as adoptive immunotherapy for cancer?

By Arai Sally   Klingemann Hans-G  

Expert Opinion on Biological Therapy, Vol. 5, Iss. 2, 2005-02 ,pp. : 163-172

Informa Healthcare

Access to resources Recommend Favorite

Recent clinical development of dendritic cell-based immunotherapy for prostate cancer

By Rini Brian  

Expert Opinion on Biological Therapy, Vol. 4, Iss. 11, 2004-11 ,pp. : 1729-1734

Informa Healthcare

Access to resources Recommend Favorite

The Emerging Picture of Human Breast Cancer as a Stem Cell-based Disease

By Cobaleda César  

Stem Cell Reviews, Vol. 4, Iss. 2, 2008-06 ,pp. : 67-79

Humana Press, Inc

Access to resources Recommend Favorite

Immunomodulation of human natural killer cell cytotoxic function by triazine and carbamate pesticides

By Whalen M.M.   Loganathan B.G.   Yamashita N.   Saito T.  

Chemico-Biological Interactions, Vol. 145, Iss. 3, 2003-06 ,pp. : 311-319

Elsevier

Access to resources Recommend Favorite